ÂÜÀòÂÒÂ×

Edward Siuda is a prolific neuroscientist with extensive experience in drug discovery and research. Currently serving as Senior Director of Neuroscience at Grünenthal Group since October 2019, Edward has previously held significant positions at Alkermes as Principal Scientist, Trevena, Inc. as Research Scientist focusing on novel GPCR targets, and as a Postdoctoral Fellow at The Janssen Pharmaceutical Companies of Johnson & Johnson, where research centered on ligand-gated ion channels in psychiatric disorders. Earlier contributions at Eli Lilly and Company included consulting on preclinical drug discovery for pain and psychiatric conditions, while experience as a Research Coordinator was gained at the Icahn School of Medicine at Mount Sinai. Edward holds a Ph.D. in Neuroscience from Washington University in St. Louis, a Master's in Zoology from Michigan State University, and a Bachelor's in Biology from Fairfield University.